Supplementary Data 4 from Personalized Circulating Tumor DNA Profiling Enables Superior and Universal Residual Disease Detection in Acute Myeloid Leukemia

Authors:

Open Access

This workbook contains the processed variant lists used for personalized measurable residual disease (MRD) tracking in the AML-CAPP-Seq study.